Nifty
Sensex
:
:
11274.20
38014.62
569.40 (5.32%)
1921.15 (5.32%)

Pharmaceuticals & Drugs

Rating :
78/99

BSE: 500680 | NSE: PFIZER

3267.85
20-Sep-2019
  • Open
  • High
  • Low
  • Previous Close
  •  3250.00
  •  3399.80
  •  3225.00
  •  3244.50
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  55678
  •  1847.00
  •  3473.00
  •  2501.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 15,042.54
  • 33.43
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 13,130.70
  • 0.68%
  • 4.81

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 63.92%
  • 4.89%
  • 13.32%
  • FII
  • DII
  • Others
  • 0.58%
  • 11.53%
  • 5.76%

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 2.35
  • 1.92

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 8.32
  • 10.07

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 43.78
  • 8.41

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 26.78
  • 33.98
  • 31.29

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.12
  • 4.95
  • 4.11

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 13.75
  • 17.00
  • 16.04

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Jun 18
Jun 17
Var%
Net Sales
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Nov 08
Nov 07
Nov 06
Nov 05
Net Sales
-
736.83
736.57
736.33
674.84
Net Sales Growth
-
0.04%
0.03%
9.11%
 
Cost Of Goods Sold
-
195.94
190.88
186.99
189.67
Gross Profit
-
540.89
545.69
549.34
485.17
GP Margin
-
73.41%
74.09%
74.61%
71.89%
Total Expenditure
-
585.58
580.08
570.64
558.84
Power & Fuel Cost
-
7.17
7.94
7.50
7.96
% Of Sales
-
0.97%
1.08%
1.02%
1.18%
Employee Cost
-
98.43
98.71
100.37
98.57
% Of Sales
-
13.36%
13.40%
13.63%
14.61%
Manufacturing Exp.
-
92.14
85.84
85.45
80.87
% Of Sales
-
12.50%
11.65%
11.60%
11.98%
General & Admin Exp.
-
49.05
48.30
45.81
45.04
% Of Sales
-
6.66%
6.56%
6.22%
6.67%
Selling & Distn. Exp.
-
99.87
106.89
103.95
96.59
% Of Sales
-
13.55%
14.51%
14.12%
14.31%
Miscellaneous Exp.
-
42.98
41.51
40.57
40.15
% Of Sales
-
5.83%
5.64%
5.51%
5.95%
EBITDA
-
151.25
156.49
165.69
116.00
EBITDA Margin
-
20.53%
21.25%
22.50%
17.19%
Other Income
-
71.10
321.80
33.47
33.24
Interest
-
0.00
0.02
0.07
0.16
Depreciation
-
11.12
9.58
13.07
13.85
PBT
-
211.22
468.69
186.01
135.23
Tax
-
119.56
111.34
56.31
41.13
Tax Rate
-
28.53%
24.67%
34.62%
36.77%
PAT
-
299.57
340.00
106.33
70.73
PAT before Minority Interest
-
299.57
340.00
106.33
70.73
Minority Interest
-
0.00
0.00
0.00
0.00
PAT Margin
-
40.66%
46.16%
14.44%
10.48%
PAT Growth
-
-11.89%
219.76%
50.33%
 
Unadjusted EPS
-
100.39
113.94
35.63
23.70

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Nov 08
Nov 07
Nov 06
Nov 05
Shareholder's Funds
901.09
649.72
439.76
375.95
Share Capital
29.84
29.84
29.84
29.84
Total Reserves
871.25
619.88
409.91
346.11
Non-Current Liabilities
-22.67
-12.98
-14.36
-9.03
Secured Loans
0.00
0.00
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
Current Liabilities
926.36
820.65
696.33
623.95
Trade Payables
108.18
92.43
137.62
120.16
Other Current Liabilities
14.50
14.17
8.14
16.26
Short Term Borrowings
0.00
0.00
0.00
0.00
Short Term Provisions
803.68
714.05
550.57
487.53
Total Liabilities
1,804.78
1,457.39
1,121.73
990.87
Net Block
50.76
60.16
69.96
75.56
Gross Block
139.90
141.61
168.14
170.15
Accumulated Depreciation
89.14
81.45
98.19
94.59
Non Current Assets
83.56
70.91
71.56
77.71
Capital Work in Progress
32.30
10.24
1.60
2.14
Non Current Investment
0.50
0.50
0.00
0.00
Long Term Loans & Adv.
0.00
0.00
0.00
0.00
Other Non Current Assets
0.00
0.00
0.00
0.00
Current Assets
1,721.22
1,383.55
1,036.82
876.46
Current Investments
0.00
0.00
0.00
0.00
Inventories
124.99
95.85
99.31
90.71
Sundry Debtors
60.31
61.69
70.10
83.54
Cash & Bank
543.65
479.91
306.94
210.15
Other Current Assets
992.26
8.17
4.22
2.14
Short Term Loans & Adv.
977.77
737.92
556.25
489.92
Net Current Assets
794.86
562.90
340.50
252.52
Total Assets
1,804.78
1,457.39
1,121.72
990.87

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Nov 08
Nov 07
Nov 06
Nov 05
Cash From Operating Activity
237.76
16.63
123.19
102.74
PBT
211.22
468.69
186.01
135.23
Adjustment
-49.50
-298.40
-8.73
7.24
Changes in Working Capital
-7.89
-33.39
11.64
-2.41
Cash after chg. in Working capital
153.83
136.91
188.92
140.06
Interest Paid
0.00
0.00
0.00
0.00
Tax Paid
-126.90
-113.33
-65.74
-37.32
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
Cash From Investing Activity
-78.87
232.35
-47.99
-73.08
Net Fixed Assets
-20.35
17.89
2.55
Net Investments
0.00
-0.50
0.00
Others
-58.52
214.96
-50.54
Cash from Financing Activity
-95.20
-75.90
-33.82
-46.02
Net Cash Inflow / Outflow
63.69
173.09
41.38
-16.36
Opening Cash & Equivalents
479.91
306.83
10.00
26.36
Closing Cash & Equivalent
543.61
479.91
51.38
10.00

Financial Ratios

Standalone /

Consolidated
Description
Nov 08
Nov 07
Nov 06
Nov 05
Book Value (Rs.)
301.96
216.74
142.90
113.68
ROA
18.37%
26.37%
10.07%
9.39%
ROE
38.71%
63.36%
27.78%
22.90%
ROCE
54.15%
84.11%
42.50%
35.52%
Fixed Asset Turnover
5.62
5.16
4.71
4.43
Receivable days
28.15
30.12
35.19
39.05
Inventory Days
50.96
44.60
43.53
41.49
Payable days
69.16
84.39
92.33
80.44
Cash Conversion Cycle
9.95
-9.68
-13.61
0.09
Total Debt/Equity
0.00
0.00
0.00
0.00
Interest Cover
0.00
0.00
2275.76
712.58

News Update:


  • Pfizer reports 23% rise in Q1 net profit
    9th Aug 2019, 14:51 PM

    Total income of the company increased by 6.89% at Rs 580.23 crore for Q1FY20

    Read More
  • Pfizer - Quarterly Results
    9th Aug 2019, 12:52 PM

    Read More
  • Pfizer planning to merge off-patent drug business with Mylan
    30th Jul 2019, 10:09 AM

    The new entity will be renamed upon the deal's closure

    Read More
  • Pfizer gets MIDC’s nod for transfer of business undertaking to Vidhi
    5th Jul 2019, 10:11 AM

    The business undertaking includes the land, plant & machinery and employees

    Read More
  • Pfizer’s parent company acquires Array BioPharma
    18th Jun 2019, 10:15 AM

    The company has offered $48 per share in cash for Array

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.